Alpha Teknova (NASDAQ:TKNO) Issues Earnings Results

Alpha Teknova (NASDAQ:TKNO) posted its quarterly earnings results on Tuesday. The company reported ($0.11) earnings per share (EPS) for the quarter, Zacks reports. Alpha Teknova had a negative return on equity of 35.30% and a negative net margin of 87.17%. Alpha Teknova updated its FY 2025 guidance to EPS.

Alpha Teknova Price Performance

Shares of Alpha Teknova stock traded up $0.18 during mid-day trading on Tuesday, reaching $6.04. 1,150,362 shares of the stock were exchanged, compared to its average volume of 281,193. Alpha Teknova has a fifty-two week low of $1.16 and a fifty-two week high of $10.37. The company has a market cap of $321.98 million, a price-to-earnings ratio of -8.16 and a beta of 0.34. The firm has a 50-day simple moving average of $8.32 and a 200 day simple moving average of $6.88. The company has a current ratio of 4.73, a quick ratio of 3.94 and a debt-to-equity ratio of 0.12.

Analyst Upgrades and Downgrades

Separately, Craig Hallum initiated coverage on Alpha Teknova in a report on Monday, February 10th. They issued a “buy” rating and a $12.00 target price for the company.

Alpha Teknova Company Profile

Alpha Teknova, Inc produces critical reagents for the research, discovery, development, and commercialization of novel therapies, vaccines, and molecular diagnostics in the United States and internationally. The company offers pre-poured media plates for cell growth and cloning; liquid cell culture media and supplements for cellular expansion; and molecular biology reagents for sample manipulation, resuspension, and purification.